American Society of Hematology, Blood, 4(126), p. 500-503, 2015
DOI: 10.1182/blood-2015-03-631937
Full text: Download
Key Points Triple therapy is well tolerated and effective in patients with chronic ITP. Relapse free survival was 92% for responders after 12 months and 76% after 24 months.